Abstract
Exogenously introduced wild-type and mutant p53 have recently been reported to enhance the human epidermal growth factor receptor (EGF-R) gene promoter activity in p53-deficient Saos2 osteosarcoma cells. A p53 binding site residing at position −265/−239 in the EGF-R proximal promoter has also been identified. We investigated the p53 regulation of EGF-R core promoter activity in human cell lines with varying endogenour p53 status. Wild-type and mutant p53A1a143 enhanced the EGF-R core promotor activity in cells that were either p53-deficient or contained wild-type or mutant endogenous p53. Upon further characterization of the various deletion fragments of the EGF-R promoter, we identified a wild-type p53 responsive 62 bp region residing at position −167/−105. The −167/−105 segment was responsive only to wild-type p53 but not to mutant p53A1a143 or p53His273. The −167/−105 segment of the EGF-R promotor contains one perfect and several imperfect consensus p53-binding half sites; indeed in gel shift experiments the 62 bp −167/−105 segment as well as the oligonucleotides corresponding to two p53 consensus half-sites within the 62 bp fragment, exhibited binding to p53-containing protein complexes. Thus, we have identified an additional wild-type p53 responsive site in the human EGF-R promoter. This site containing consensus p53-binding sequences resides at position −167/−105 and is proximal to recently identified p53 binding element located at position −265/−239 in the EGF-R promotor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheikh, M., Carrier, F., Johnson, A. et al. Identification of an additional p53-responsive site in the human epidermal growth factor receptor gene promotor. Oncogene 15, 1095–1101 (1997). https://doi.org/10.1038/sj.onc.1201264
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201264
Keywords
This article is cited by
-
Multiple testing for gene sets from microarray experiments
BMC Bioinformatics (2011)
-
PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers
Oncogene (2009)
-
RIP1 links inflammatory and growth factor signaling pathways by regulating expression of the EGFR
Cell Death & Differentiation (2008)
-
Loss of p53 induces epidermal growth factor receptor promoter activity in normal human keratinocytes
Oncogene (2008)
-
Activation of the p53–p21Cip1 pathway is required for CDK2 activation and S-phase entry in primary rat hepatocytes
Oncogene (2008)